AU2002342600A1 - Use of selective potassium channel openers - Google Patents

Use of selective potassium channel openers

Info

Publication number
AU2002342600A1
AU2002342600A1 AU2002342600A AU2002342600A AU2002342600A1 AU 2002342600 A1 AU2002342600 A1 AU 2002342600A1 AU 2002342600 A AU2002342600 A AU 2002342600A AU 2002342600 A AU2002342600 A AU 2002342600A AU 2002342600 A1 AU2002342600 A1 AU 2002342600A1
Authority
AU
Australia
Prior art keywords
potassium channel
channel openers
selective potassium
selective
openers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002342600A
Inventor
Jeppe Sturis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2002342600A1 publication Critical patent/AU2002342600A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002342600A 2001-11-30 2002-11-28 Use of selective potassium channel openers Abandoned AU2002342600A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101774 2001-11-30
DKPA200101774 2001-11-30
PCT/DK2002/000797 WO2003045954A1 (en) 2001-11-30 2002-11-28 Use of selective potassium channel openers

Publications (1)

Publication Number Publication Date
AU2002342600A1 true AU2002342600A1 (en) 2003-06-10

Family

ID=8160862

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002342600A Abandoned AU2002342600A1 (en) 2001-11-30 2002-11-28 Use of selective potassium channel openers

Country Status (2)

Country Link
AU (1) AU2002342600A1 (en)
WO (1) WO2003045954A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003239780A1 (en) * 2002-07-04 2004-01-23 Novo Nordisk A/S Polymorphic forms of a 4h-thieno(3,2-e)-1,2,4-thiadiazine 1,1-dioxide derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707003A (en) * 1996-01-17 1999-07-20 Novo Nordisk As Compound processes to prepare it for the treatment or prevention of diseases of the endocrine system and for the manufacture of pharmaceutical drugs and the use of a compound
EP0877748B1 (en) * 1996-01-17 2004-11-03 Université de Liège Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
CA2294830A1 (en) * 1997-07-16 1999-01-28 John Bondo Hansen Fused 1,2,4-thiadiazine derivatives, their preparation and use
EP1140945B1 (en) * 1998-12-18 2003-06-04 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
WO2002000665A1 (en) * 2000-06-26 2002-01-03 Novo Nordisk A/S Use of potassium channel openers for the treatment of insulitis

Also Published As

Publication number Publication date
WO2003045954A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
GB2390091B (en) Bisarylamines as potassium channel openers
AU2003294441A1 (en) 1-aryl-2-hydroxyethyl amides as potassium channel openers
AU5557700A (en) New uses for potassium channel openers
AU2003230401A1 (en) Bis-benzimidazoles and related compounds as potassium channel modulators
AU2002318330A1 (en) Multi-channel communications transreceiver
AU2002238351A1 (en) Soft cannula
AU2001234871A1 (en) Optimized sampling rate
AU2001265839A1 (en) Use of potassium channel agonists for the treatment of cancer
AU2003295781A1 (en) Arylcyclopropylcarboxylic amides as potassium channel openers
EP1421936A4 (en) Potassium channel opener
AU2002249809A1 (en) Potassium channel inhibitors
AU2003295782A1 (en) Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
AU2003250479A1 (en) Communication channel selection
WO2002010164A3 (en) Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
AU2002361852A1 (en) Potassium fluoroionophore
AU2002365289A1 (en) Use of selective potassium channel openers
AU2002342600A1 (en) Use of selective potassium channel openers
AU2001265841A1 (en) Use of potassium channel openers for the treatment of insulitis
AU2002338572A1 (en) 66784, a novel human potassium channel and uses therefor
AU2002252428A1 (en) Human potassium channel
AU2002253575A1 (en) Potassium channel opener
AU2002306716A1 (en) Bisarylamines as potassium channel openers
AU3835499A (en) Potassium channel subunit
AU2002337777A1 (en) Methods of using 33751, a human potassium channel family member
EP1347049A4 (en) Novel potassium channel

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase